MA
DTIL icon

MUFG Americas’s Precision BioSciences DTIL Stock Holding History

MUFG Americas’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-220
Closed -$92K – 717
2019
Q4 		$92K Hold
220
– – ﹤0.01% 468
2019
Q3 		$55K Buy
220
+92
+72% +$29.9K ﹤0.01% 526
2019
Q2 		$51K Buy
+128
New +$51.5K ﹤0.01% 523

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
ACWM
Adams Chetwood Wealth Management Durham, North Carolina $176M AUM 8.48% 1-Year Est. Return

MUFG Americas's DTIL Position: Q1 2020 in Review

MUFG Americas sold out of Precision BioSciences (DTIL) in Q1 2020, closing a stake of 220 shares — an estimated $92K sold.

MUFG Americas first reported a position in DTIL in Q2 2019 and held it in 3 quarters. The position peaked at $92K in Q4 2019. 109 funds tracked by Wall St. Rank hold DTIL as of Q1 2020.

  • MUFG Americas reported no remaining Precision BioSciences position as of Q1 2020 after selling out during the quarter.
  • MUFG Americas sold 220 Precision BioSciences shares in Q1 2020, an estimated $92K.
  • MUFG Americas first reported a position in Precision BioSciences in Q2 2019 and held it in 3 quarters.
  • MUFG Americas's Precision BioSciences position peaked at $92K in Q4 2019.
  • 109 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2020.

Based on MUFG Americas's 13F filing for Q1 2020, filed 24 Apr 2020.